Blog

Part 21: The right of access to large language models

If large language models contain or generate personal data, sooner or later data subjects will want to know about it. But how should access requests with regard to personal data contained in an LLM be answered in a compliant...

Part 20: Risk-based approach: Not all AI applications harbour high risks

It is often said that the use of AI comes with risks. This is true and we ourselves have published a tool that can be used to assess such AI risks and which is enjoying some popularity. However, where AI applications do not...

Federal Supreme Court changes practice on intercantonal double taxation

In the event of possible intercantonal double taxation, the new practice of the Federal Supreme Court offers taxpayers improved opportunities to take action.

New FINMA Guidance on Cyber Risk Supervision Published

On 7 June 2024 FINMA published guidance on its findings from its cyber risk supervision and related topics.

Part 19: Language models with and without personal data

We have explained the technical aspects of a large language model in part 17 of our blog. But what conclusions can we draw from this in terms of data protection? Does an LLM contain personal data within the meaning of the GDPR and...

Modernisation of the Foreign Nationals and Integration Act - effects on residence permits

The forthcoming modernisation of the Foreign Nationals and Integration Act ("FNIA") could have an impact on residence permits for foreign nationals. In view of the planned changes in the area of gainful employment and the granting...

Der (Wieder-)Verkauf von eigenen Aktien mit Gewinn stellt keinen steuerbaren Ertrag dar

Leitentscheid des Schweizerischen Bundesgerichts (9C_135/2023)

Das Bundesgericht hat in seinem Urteil vom 6. Juni 2024, eine börsenkotierte Gesellschaft betreffend, festgehalten, der steuerneutral verbuchte Erlös aus dem Verkauf...

The BIOSECURE Act: How relevant is it for Swiss biotechnology companies?

The conflict between the USA and China continues to escalate and will probably also have an impact on the biotechnology sector.

Why you should monitor your trademark

Your trademark is registered, correctly labeled and successfully used in the market.

Parallel import of medicinal products into Switzerland

Implications of the new regulations

The import of medicinal products authorized abroad into Switzerland can have a variety of motives, the main ones being to ensure cross-border medical supplies, offset excess stocks in foreign...